Reduced SRCIN1 expression led to decreased cell viability in the MCF-7, T47D and MDA-MB-231 breast cancer cell lines, as confirmed by more than three technical and biological replicates (Figure 5C–E). This evidence concerns the gene SRCIN1 and breast carcinoma.